Kristen M Beavers1, L Douglas Case2, Caroline S Blackwell3, Jeffery A Katula4, David C Goff5, Mara Z Vitolins3. 1. Department of Internal Medicine, Wake Forest School of Medicine, Winston-Salem, NC, United States; Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, United States. Electronic address: beaverkm@wfu.edu. 2. Department of Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, NC, United States. 3. Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston-Salem, NC, United States. 4. Department of Health and Exercise Science, Wake Forest University, Winston-Salem, NC, United States. 5. Department of Epidemiology, Colorado School of Public Health, Aurora, CO, United States.
Abstract
OBJECTIVE: To assess the extent to which initial, intentional weight loss-associated improvements in glucose tolerance and insulin action are diminished with weight regain. METHODS:138 overweight and obese (BMI: 32.4±3.9kg/m(2)), adults (59.0±9.7 years), with pre-diabetes were followed through a 6-month weight loss intervention and subsequent 18-month weight maintenance period, or usual care control condition. Longitudinal change in weight (baseline, 6, 24 months) was used to classify individuals into weight pattern categories (Loser/Maintainer (LM), n= 50; Loser/Regainer (LR), n=51; and Weight Stable (WS), n=37). Fasting plasma glucose (FPG), insulin, and insulin resistance (HOMA-IR) were measured at baseline, 6, 12, 18 and 24 months and model adjusted changes, by weight pattern category, were assessed. RESULTS:LMs and LRs lost 8.3±4.7kg (8.7±4.5%) and 9.6±4.7kg (10.2±4.7%) during the first 6 months, respectively. LM continued to lose 1.1±3.4kg over the next 18 months (9.9±6.5% reduction from baseline; p<0.05), while LRs regained 6.5±3.7kg (3.3±5.3% reduction from baseline; p<0.05). Weight change was directly associated with change in all DM risk factors (all p<0.01). Notably, despite an absolute reduction in body weight (from baseline to 24 months) achieved in the LR group, 24-month changes in FPG, insulin, and HOMA-IR did not differ between WS and LR groups. Conversely, LM saw sustained improvements in all measured DM risk factors. CONCLUSIONS:Significant weight loss followed by weight loss maintenance is associated with sustained improvements in FPG, insulin, and HOMA-IR; conversely, even partial weight regain is associated with regression of initial improvements in these risk factors towards baseline values.
RCT Entities:
OBJECTIVE: To assess the extent to which initial, intentional weight loss-associated improvements in glucose tolerance and insulin action are diminished with weight regain. METHODS: 138 overweight and obese (BMI: 32.4±3.9kg/m(2)), adults (59.0±9.7 years), with pre-diabetes were followed through a 6-month weight loss intervention and subsequent 18-month weight maintenance period, or usual care control condition. Longitudinal change in weight (baseline, 6, 24 months) was used to classify individuals into weight pattern categories (Loser/Maintainer (LM), n= 50; Loser/Regainer (LR), n=51; and Weight Stable (WS), n=37). Fasting plasma glucose (FPG), insulin, and insulin resistance (HOMA-IR) were measured at baseline, 6, 12, 18 and 24 months and model adjusted changes, by weight pattern category, were assessed. RESULTS: LMs and LRs lost 8.3±4.7kg (8.7±4.5%) and 9.6±4.7kg (10.2±4.7%) during the first 6 months, respectively. LM continued to lose 1.1±3.4kg over the next 18 months (9.9±6.5% reduction from baseline; p<0.05), while LRs regained 6.5±3.7kg (3.3±5.3% reduction from baseline; p<0.05). Weight change was directly associated with change in all DM risk factors (all p<0.01). Notably, despite an absolute reduction in body weight (from baseline to 24 months) achieved in the LR group, 24-month changes in FPG, insulin, and HOMA-IR did not differ between WS and LR groups. Conversely, LM saw sustained improvements in all measured DM risk factors. CONCLUSIONS: Significant weight loss followed by weight loss maintenance is associated with sustained improvements in FPG, insulin, and HOMA-IR; conversely, even partial weight regain is associated with regression of initial improvements in these risk factors towards baseline values.
Authors: Edward C Weiss; Deborah A Galuska; Laura Kettel Khan; Cathleen Gillespie; Mary K Serdula Journal: Am J Prev Med Date: 2007-07 Impact factor: 5.043
Authors: Kitt Falk Petersen; Sylvie Dufour; Douglas Befroy; Michael Lehrke; Rosa E Hendler; Gerald I Shulman Journal: Diabetes Date: 2005-03 Impact factor: 9.461
Authors: William C Knowler; Elizabeth Barrett-Connor; Sarah E Fowler; Richard F Hamman; John M Lachin; Elizabeth A Walker; David M Nathan Journal: N Engl J Med Date: 2002-02-07 Impact factor: 91.245
Authors: Pilvikki Absetz; Raisa Valve; Brian Oldenburg; Heikki Heinonen; Aulikki Nissinen; Mikael Fogelholm; Vesa Ilvesmäki; Martti Talja; Antti Uutela Journal: Diabetes Care Date: 2007-06-22 Impact factor: 19.112
Authors: R L Hanson; K M Narayan; D R McCance; D J Pettitt; L T Jacobsson; P H Bennett; W C Knowler Journal: Diabetes Date: 1995-03 Impact factor: 9.461
Authors: Mara Z Vitolins; Caroline S Blackwell; Jeffrey A Katula; Scott P Isom; L Douglas Case Journal: Diabetes Care Date: 2019-07-11 Impact factor: 19.112
Authors: Ricardo J Samms; Michael E Christe; Kyla Al Collins; Valentina Pirro; Brian A Droz; Adrienne K Holland; Jessica L Friedrich; Samantha Wojnicki; Debra L Konkol; Richard Cosgrove; Ellen Ps Conceição Furber; Xiaoping Ruan; Libbey S O'Farrell; Annie M Long; Mridula Dogra; Jill A Willency; Yanzhu Lin; Liyun Ding; Christine C Cheng; Over Cabrera; Daniel A Briere; Jorge Alsina-Fernandez; Ruth E Gimeno; Julie S Moyers; Tamer Coskun; Matthew P Coghlan; Kyle W Sloop; William C Roell Journal: J Clin Invest Date: 2021-06-15 Impact factor: 14.808
Authors: Mira Aubuchon; Ying Liu; Gregory F Petroski; Tom R Thomas; Alex J Polotsky Journal: Syst Biol Reprod Med Date: 2016-05-18 Impact factor: 3.061
Authors: Maria J Pereira; Per Lundkvist; Prasad G Kamble; Joey Lau; Julian G Martins; C David Sjöström; Volker Schnecke; Anna Walentinsson; Eva Johnsson; Jan W Eriksson Journal: Diabetes Ther Date: 2018-06-13 Impact factor: 2.945